• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED IMMULITE 2000 XPI HUMAN CHORIONIC GONADOTROPIN (HCG); IMMULITE 2000 HCG

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED IMMULITE 2000 XPI HUMAN CHORIONIC GONADOTROPIN (HCG); IMMULITE 2000 HCG Back to Search Results
Model Number N/A
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/08/2021
Event Type  malfunction  
Event Description
The customer reported imprecision for a patient sample with immulite 2000 hcg.The initial result was reported to the physician(s); however, it is unknown if the result was questioned.There are no reports that treatment was altered or prescribed or adverse health consequences due to the imprecision of the immulite 2000 hcg results.
 
Manufacturer Narrative
An outside of the united states (ous) customer contacted the customer care center (ccc) and reported imprecision on a patient sample using the immulite 2000 xpi human chorionic gonadotropin (hcg) assay.The spyfiles, maindata, daily events and errorlog were received and are under review.Siemens healthcare diagnostics is investigating the cause of the event.The limitations section of the instructions for use states the following: "for diagnostic purposes, the results obtained from this assay should always be used in combination with the clinical examination, patient medical history, and other findings.".
 
Manufacturer Narrative
The initial mdr 1219913-2021-00028 was filed on january 21, 2022.Additional information - january 26, 2022 the lot number and expiration date were unknown when the initial mdr was filed.This information has been added to section d4.An outside the united states (ous) customer reported immulite 2000/xpi hcg non-reproducible patient results.The initial patient result is often higher than clinically expected and repeat of the same sample on the same system is lower and in alignment with clinical expectation.This customer has not reported any concerns with immulite 2000/xpi hcg adjustment and/or quality control (qc) performance.Hcg within run precision has been verified and preanalytic's have been investigated at this customer site.Siemens continues to investigate.
 
Manufacturer Narrative
The initial mdr 1219913-2022-00028, was filed on 21 january 2022 and mdr 1219913-2022-00028 supplemental 1 was filed on 19 february 2022.17 march 2022 - correction: in mdr 1219913-2022-00028 supplemental 1, section b4 (date of this report) was listed as 18 february 2022, however the report was filed on 19 february 2022.22 february 2022 - additional information: siemens healthcare diagnostics further investigated the issue and confirmed the potential for falsely elevated hcg results due to sample carryover.This can be observed when a sample is assayed for hcg immediately after an undiluted sample with a hcg value of >5000 miu/ml.This issue impacts serum and urine patient samples, as well as quality control samples and adjustors.The effect of carryover varies based on the concentration of the high hcg sample.Starting 2022-02-22 an urgent medical device correction (umdc, letter imc22-04.A.Us) was sent to us customers, and an urgent field safety notice (ufsn, letter imc22-04.A.Ous) was sent to outside the us (ous).The umdc and ufsn explain the potential for carryover from high hcg samples into the next sample assayed for hcg on the immulite 2000/immulite 2000 xpi, and provides instructions to the customers.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMMULITE 2000 XPI HUMAN CHORIONIC GONADOTROPIN (HCG)
Type of Device
IMMULITE 2000 HCG
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED
glyn rhonwy
llanberis, gwynedd, LL55 4EL
UK  LL55 4EL
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED
glyn rhonwy
uk registration #: 3002806944
gwynedd, llanberis LL55 4EL
UK   LL55 4EL
Manufacturer Contact
stacy loukos
333 coney st
e. walpole, MA 02032
3392064073
MDR Report Key13321859
MDR Text Key284888479
Report Number1219913-2022-00028
Device Sequence Number1
Product Code DHA
UDI-Device Identifier00630414961132
UDI-Public00630414961132
Combination Product (y/n)N
Reporter Country CodeRS
PMA/PMN Number
K990222
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Remedial Action Recall
Type of Report Initial,Followup,Followup
Report Date 03/17/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/21/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2022
Device Model NumberN/A
Device Catalogue NumberN/A
Device Lot Number463
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/22/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction Number2432235-03/04/2022-002-C
Patient Sequence Number1
-
-